Oct. 2 at 3:12 PM
$PPCB This is a
$20 stock very soon now. The patent has also been granted in other major jurisdictions such as Europe, Japan and throughout Southeast Asia. PRP is targeting the global metastatic cancer treatment market, projected to be worth US
$111.2 billion by 2027, according to Emergen Research.
$AGMH $WOLF